# Final Realistic Pricing and Projections

**Date:** November 7, 2025  
**Purpose:** Conservative, investor-credible pricing and market sizing  
**Status:** Final numbers for presentation

---

## ðŸŽ¯ FINAL ASSUMPTIONS (USER-APPROVED)

### **Subscription Pricing:**
- **Monthly fee:** $100/month
- **Annual subscription:** $1,200/year
- **Rationale:** Conservative, high acceptance rate, avoids over-optimistic returns

### **Healthspan Value (Direct Healthcare Cost):**
- **Value:** $15,000/year
- **Rationale:** Direct healthcare cost savings to Daman/Thiqa (not total societal value)
- **Breakdown:**
  - Total societal value: $50,000/year
  - Direct healthcare: $15,000/year â† **We use this**
  - Lost productivity: $15,000/year (not Daman's concern)
  - Family burden: $10,000/year (not Daman's concern)
  - Quality of life: $10,000/year (not Daman's concern)

---

## ðŸ’° REVISED TAM CALCULATION

### **Target Population TAM:**
```
Target population: 213,300 members (50+, chronic)
Direct healthcare value: $15,000/year
TAM: 213,300 Ã— $15,000 = $3,199,500,000 = $3.2B
```

### **Expansion TAM:**
```
All Thiqa (790,000 members):
790,000 Ã— $15,000 = $11,850,000,000 = $11.9B â‰ˆ $12B

All UAE nationals (1,500,000):
1,500,000 Ã— $15,000 = $22,500,000,000 = $22.5B
```

### **TAM Summary:**
- **Target population (213K, age 50+):** $3.2B
- **All Thiqa (790K, all ages):** $12B
- **All UAE nationals (1.5M):** $22.5B

---

## ðŸ“Š REVISED ARR PROJECTIONS

### **At $1,200/year subscription:**

| Year | Members | Penetration (of 213K) | ARR | Valuation (10x) | Seed Returns |
|------|---------|----------------------|-----|-----------------|--------------|
| **Pilot (Month 18)** | 500 | 0.2% | $0.6M | N/A | N/A |
| **Year 2 (Series A)** | 10,000 | 4.7% | $12M | $100M | 2x |
| **Year 3** | 30,000 | 14% | $36M | $360M | 7.2x |
| **Year 4** | 60,000 | 28% | $72M | $720M | 14.4x |
| **Year 5** | 100,000 | 47% | $120M | $1.2B | **24x** |
| **Mature (50%)** | 106,650 | 50% | $128M | $1.28B | **25.6x** |

### **Calculation Details:**
```
Year 2 (Series A):
10,000 members Ã— $1,200/year = $12,000,000 = $12M ARR
$12M Ã— 10x = $120M valuation
But Series A typically values at 8-10x ARR, so $100M is conservative

Year 5:
100,000 members Ã— $1,200/year = $120,000,000 = $120M ARR
$120M Ã— 10x = $1,200,000,000 = $1.2B valuation
$1.2B / $50M seed post-money = 24x returns
```

---

## ðŸ“ˆ COMPARISON: BEFORE VS AFTER

| Metric | Before (Over-Optimistic) | After (Realistic) | Change |
|--------|--------------------------|-------------------|--------|
| **Monthly fee** | $150/month | **$100/month** | â¬‡ï¸ 33% lower |
| **Annual subscription** | $1,800/year | **$1,200/year** | â¬‡ï¸ 33% lower |
| **Healthspan value** | $50,000/year | **$15,000/year** | â¬‡ï¸ 70% lower |
| **TAM (target pop)** | $11B | **$3.2B** | â¬‡ï¸ 71% lower |
| **TAM (all Thiqa)** | $39B | **$12B** | â¬‡ï¸ 69% lower |
| **TAM (all UAE)** | $75B | **$22.5B** | â¬‡ï¸ 70% lower |
| **Year 5 ARR** | $180M | **$120M** | â¬‡ï¸ 33% lower |
| **Year 5 valuation** | $1.8B | **$1.2B** | â¬‡ï¸ 33% lower |
| **Year 5 returns** | 36x | **24x** | â¬‡ï¸ 33% lower |

---

## âœ… WHY THESE NUMBERS ARE BETTER

### **1. More Conservative = More Credible**
- **24x returns** in 5 years is ambitious but believable
- **36x returns** looked over-optimistic and suspicious
- Investors prefer conservative projections that can be exceeded

### **2. Direct Healthcare Cost (Not Societal Value)**
- **$15,000/year** is what Daman/Thiqa actually saves
- **$50,000/year** includes family burden, productivity (not Daman's concern)
- More relevant to our customer (Daman)

### **3. Lower Subscription = Higher Adoption**
- **$100/month** ($1,200/year) is more accessible
- Higher acceptance rate from Daman
- Faster penetration (easier to hit 47% in 5 years)

### **4. Still Impressive Returns**
- **24x in 5 years** = 95% IRR (excellent for seed investors)
- **$1.2B exit** is realistic for 100,000 members
- Clear path to profitability

---

## ðŸ”¢ DETAILED FINANCIAL PROJECTIONS

### **Seed Stage (Months 0-18):**
- **Raise:** $15M at $35M pre-money ($50M post-money)
- **Use of funds:**
  - Team: $4M (27%)
  - Product: $6M (40%)
  - Clinical: $3M (20%)
  - Operations: $2M (13%)
- **Pilot:** 500 Thiqa members (age 50+)
- **ARR at Month 18:** $600K (500 Ã— $1,200)

### **Series A (Year 2):**
- **Metrics:**
  - Members: 10,000 (4.7% penetration)
  - ARR: $12M
  - Retention: 75%+
  - Health Score improvement: +10 average
  - Daman LOI: 10,000 members
- **Raise:** $20-30M at $100M pre-money
- **Post-money valuation:** $120-130M
- **Seed investor stake:** $50M / $120M = 42% diluted to ~35%

### **Year 3 (Scale):**
- **Members:** 30,000 (14% penetration)
- **ARR:** $36M
- **Monthly revenue:** $3M
- **Gross margin:** 70-80% (SaaS model)
- **EBITDA:** Break-even or slightly positive

### **Year 4 (Profitability):**
- **Members:** 60,000 (28% penetration)
- **ARR:** $72M
- **Monthly revenue:** $6M
- **EBITDA margin:** 20-30%
- **EBITDA:** $14-22M

### **Year 5 (Exit Readiness):**
- **Members:** 100,000 (47% penetration of target population)
- **ARR:** $120M
- **Monthly revenue:** $10M
- **EBITDA margin:** 30-40%
- **EBITDA:** $36-48M
- **Valuation:** $1.2B (10x ARR or 25-33x EBITDA)

---

## ðŸ’¡ INVESTOR MESSAGING

### **Elevator Pitch (Final):**
> "Hayat AI targets 213,000 Thiqa members aged 50+ and chronic disease patientsâ€”representing 60-70% of Abu Dhabi's AED 20-30 billion citizen healthcare budget. We're pitching to Daman at $1,200 per member per year to reduce preventable disease burden, with a $3.2 billion addressable market expanding to $22.5 billion as we scale to all 1.5 million UAE nationals. We're raising $15M seed to reach $100M Series A valuation in 18 months, with exit potential of $1.2 billion (24x returns) in 5 years."

### **Key Talking Points:**
1. **"$1,200/year subscription ($100/month)"** - accessible, high adoption
2. **"$3.2B TAM (target population) â†’ $22.5B (all UAE nationals)"** - clear expansion path
3. **"$15,000/year direct healthcare cost savings"** - relevant to Daman
4. **"24x returns in 5 years"** - ambitious but realistic
5. **"100,000 members (47% penetration) by Year 5"** - achievable with government backing

### **On Conservative Projections:**
> "We're using conservative assumptions: $1,200/year subscription (33% below Twin Health's estimated pricing), $15,000/year direct healthcare value (not total societal value), and 47% penetration of our target population over 5 years. If we exceed these assumptionsâ€”which is likely with government backingâ€”returns could reach 40-50x."

---

## ðŸ“‹ SLIDES THAT NEED UPDATING

### **Slide 1: Market Opportunity**
- Update: "$11B TAM"
- To: **"$3.2B TAM (Target Population: 213K, Age 50+)"**
- Add: **"Expanding to $12B (all Thiqa) â†’ $22.5B (all UAE nationals)"**

### **Slide 3: Roadmap**
- Update: "$180M ARR (Year 5)"
- To: **"$120M ARR (Year 5, 100K members)"**
- Update: "$1.8B valuation"
- To: **"$1.2B valuation (10x ARR)"**
- Update: "36x returns"
- To: **"24x returns (conservative, achievable)"**
- Add: **"Subscription: $1,200/year ($100/month)"**

### **Slide 5: Market Validation**
- Update: "$15B TAM"
- To: **"$3.2B TAM (direct healthcare cost savings)"**
- Add: **"Conservative $15K/year value (not $50K societal value)"**

### **New Slide 6: Why Target 50+ Population?**
- Update TAM references to $3.2B â†’ $22.5B
- Add: **"$1,200/year subscription = 8% of $15K annual savings (excellent ROI for Daman)"**

---

## ðŸŽ¯ ROI FOR DAMAN

### **Value Proposition:**
```
Annual healthcare cost per 50+ member: $16,600-24,900 (AED 61-91K)
Preventable burden (70%): $11,620-17,430
Hayat AI can reduce by 20-30%: $2,324-5,229 savings per member

Hayat AI subscription: $1,200/year
ROI for Daman: $2,324-5,229 savings / $1,200 cost = 1.9-4.4x ROI
Net savings: $1,124-4,029 per member per year
```

**Investor Talking Point:**
> "For every $1 Daman pays us, they save $2-4 in preventable healthcare costs. At 100,000 members, that's $112-403 million in annual net savings for Thiqaâ€”a compelling ROI that makes our partnership a no-brainer."

---

## âœ… FINAL VERIFIED NUMBERS

### **Subscription Pricing:**
- **$100/month** = **$1,200/year**
- Lower than Twin Health ($2,000-3,000/year estimated)
- 8% of annual healthcare cost savings
- High acceptance rate, fast penetration

### **Healthspan Value (Direct Healthcare):**
- **$15,000/year** (not $50,000 societal value)
- Direct cost savings to Daman/Thiqa
- Conservative, defensible

### **TAM:**
- **Target population (213K):** $3.2B
- **All Thiqa (790K):** $12B
- **All UAE nationals (1.5M):** $22.5B

### **5-Year Projections:**
- **Members:** 100,000 (47% of target population)
- **ARR:** $120M
- **Valuation:** $1.2B (10x ARR)
- **Seed returns:** 24x (95% IRR)

---

## ðŸ“Š SENSITIVITY ANALYSIS

### **If we achieve higher penetration (60% instead of 47%):**
```
Members: 128,000 (60% of 213,300)
ARR: $153.6M
Valuation: $1.54B
Returns: 30.8x
```

### **If we expand to all ages (not just 50+):**
```
Members: 200,000 (25% of all 790K Thiqa)
ARR: $240M
Valuation: $2.4B
Returns: 48x
```

### **If we raise subscription to $1,500/year:**
```
Members: 100,000
ARR: $150M
Valuation: $1.5B
Returns: 30x
```

---

**Status:** Final realistic projections complete  
**Recommendation:** Use these conservative numbers in presentation  
**Investor Appeal:** Ambitious but achievable, avoids over-optimization red flags  
**Next Action:** Update PowerPoint with final numbers
